ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 571

Description of Distribution of Active Inflammatory Lesions On Magnetic Resonance Imaging of the Sacroiliac Joints and the Spine in Patients with Early Axial Spondyloarthritis – Analysis of the Esther Trial Baseline Data

In-Ho Song1, Christian Althoff2, Hildrun Haibel1, Joachim Listing3, Anja Weiß4, Bruce Freundlich5, Martin Rudwaleit6 and Joachim Sieper7, 1Medical Department I, Rheumatology, Charité Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany, 2Radiology, Charite Universitätsmedizin Berlin, Campus Mitte, Berlin, Germany, 3German Rheumatism Research Center, Berlin, Germany, 4German Rheumatism Research Centre, Berlin, Germany, 5University of Pennsylvania, Philadelphia, PA, 6Endokrinologikum Berlin, Berlin, Germany, 7Medical Department I, Rheumatology, Charité Universitätesmedizin Berlin, Berlin, Germany

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Ankylosing spondylitis (AS), imaging techniques, Magnetic resonance imaging (MRI), spondylarthropathy and tumor necrosis factor (TNF)

  • Tweet
  • Email
  • Print
Session Information

Title: Spondylarthropathies and Psoriatic Arthritis: Clinical Aspects and Treatment

Session Type: Abstract Submissions (ACR)

Background/Purpose: To address the question whether active inflammation starts at specific sites of the sacroiliac joints (SI-joints) and/ or the spine.  

Methods:

Wb-MRIs of 75 patients with early axial spondyloarhtritis (SpA) with a disease duration of < 5 years [1] were scored for active inflammatory lesions on STIR sequences and T1 weighted images in the 23 vertebral units (VUs) of the spine and in the 8 sacroiliac (SI)-joint quadrants. Scoring was performed by two blinded radiologists.  

Results:

In the total group of patients, 52% (39/75) showed active inflammation only at the SI-joints (active sacroiliitis), 41.3% (31/75) in the SI-joints and the spine and 5.3 (4/75) only in the spine (isolated spinal inflammation).

Mean scores for active inflammatory changes were 6.7 (SD 5.8) out of possible 24 points for the SI-joints and 1.9 (SD 3.3) out of possible 69 for the spine.

Active inflammation in the SI-joint quadrants were found as the following (in decreasing order): quadrant I (sacral bone, upper quadrant; 66% of patients, n= 50); quadrant II (sacral bone, lower quadrant; 60%, n= 45), quadrant IV (iliac bone, upper quadrant, 53%, n= 40), quadrant III (iliac bone, lower quadrant, 69%, n=52).  

The most frequently affected sites of active inflammation in the spine were the lower thoracic spine and the lumbar spine: in decreasing order the most frequently affected VUs were T6/T7 (n= 11), T10/T11 (n= 11), T7/T8 (n= 10), L1/L2 (n= 10) and L4/L5 (n= 9) and L5/S1 (n= 9).  The cervical spine was less often affected.

Table: Distribution of active inflammation in the Sacroiliac Joint Quadrants and the Spinal vertebral units

Anatomie site

Percentage of affected patients

SI-joint quadrant I (sacral bone, upper quadrant)

66%

SI-joint quadrant II (sacral bone, lower quadrant)

60%

SI-joint quadrant IV (iliac bone, upper quadrant)

53%

SI-joint quadrant III (iliac bone, lower quadrant

69%

C2/C3

3%

C3/C4

1%

C4/C5

1%

C5/C6

4%

C6/C7

7%

C7/T1

3%

T1/T2

4%

T2/T3

7%

T3/T4

7%

T4/T5

9%

T5/T6

8%

T6/T7

15%

T7/T8

13%

T8/T9

11%

T9/T10

8%

T10/T11

15%

T11/T12

5%

T12/L1

8%

L1/L2

13%

L2/L3

9%

L3/L4

11%

L4/L5

12%

L5/S1

12%

[1] Song I.-H. et al.  2011.  Ann Rheum Dis. 2011 Apr;70(4):590-6.

Conclusion:

In this cohort of early axial SpA patients there was no significant predilection of SI-joint quadrants affected by active inflammtion. In the spine the thoracic and lumbar parts were mostly affected.


Disclosure:

I. H. Song,

Pfizer Pharmaceuticals, Merck Sharp Dohme/Schering Plough, Abbott Immunology Pharmaceuticals,

5;

C. Althoff,
None;

H. Haibel,

Pfizer Pharmaceuticals, Merck Sharp Dohme/Schering Plough, Abbott Immunology Pharmaceuticals.,

5;

J. Listing,
None;

A. Weiß,
None;

B. Freundlich,

former employee from Pfizer,

3;

M. Rudwaleit,

Abbott, BMS, MSD, Pfizer, Roche, and UCB,

5;

J. Sieper,

Abbott, Merck, Pfizer, and UCB,

2,

Abbott, Merck, Pfizer, and UCB,

5,

Abbott, Merck, Pfizer, and UCB,

8.

  • Tweet
  • Email
  • Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/description-of-distribution-of-active-inflammatory-lesions-on-magnetic-resonance-imaging-of-the-sacroiliac-joints-and-the-spine-in-patients-with-early-axial-spondyloarthritis-analysis-of-the/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology